Status:
COMPLETED
Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery
Lead Sponsor:
Maasstad Hospital
Conditions:
Spinal Bupivacaine/Morphine in Laparoscopic Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to determine if a single spinal shot of morphine can decrease post-operative opioid-use, and thereby decrease opioid side-effects and lead to a quicker recovery after su...
Detailed Description
We expect that in laparoscopic gastro-intestinal surgery, a single shot spinal with bupicavaine/morphine will result in a better analgesia in hte first 48 hours. Herby the patients will require less s...
Eligibility Criteria
Inclusion
- Laparoscopic Gastro-intestinal surgery
Exclusion
- Bariatric surgery, gastric surgery, rectal surgery, kidney failure, aorta-valve stenosis, coagulation disorders, emergency surgery
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT02284282
Start Date
August 1 2014
End Date
November 1 2016
Last Update
August 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maasstad Hospital
Rotterdam, Netherlands, 3079DZ